4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0001193125-25-267545
Chief Executive Officer sold 40,000 shares at an average $74.58 ($2,983,119)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
BELANOFF JOSEPH K · Chief Executive Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-11-03 | Sale : show line 1 in the form 10b5-1 | −11,218 | $74.08 | $831,014 | 2,770,152 | I |
| 2025-11-05 | Sale : show line 2 in the form 10b5-1 | −14,355 | $74.20 | $1,065,084 | 2,755,797 | I |
| 2025-11-05 | Sale : show line 3 in the form 10b5-1 | −10,837 | $75.14 | $814,262 | 2,744,960 | I |
| 2025-11-05 | Sale : show line 4 in the form 10b5-1 | −3,590 | $75.98 | $272,760 | 2,741,370 | I |
| Open-market sales · 40,000 sh · avg $74.58 · $2,983,119 | ||||||
Loading xslF345X05/ownership.xml…